Eli Lilly and Co., the Indianapolis drug maker, will settle an investigation by federal and state authorities over the antipsychotic Zyprexa. The government’s investigation is related to past marketing and promotional practices for Zyprexa, which has been one of Lilly’s biggest-selling drugs since its introduction in 1996. You will recall that recently the company paid $15 million to settle a single lawsuit with the state of Alaska. Also, in October, Lilly resolved a 32-state claim over sales, marketing and promotion of Zyprexa for $62 million. That was a very good and relatively cheap settlement – considering the conduct and damages – and one that Lilly had to like. The government’s investigation of Zyprexa has been ongoing for five years. The latest settlement brings that inquiry to a close.
Source: Indianapolis Star
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.